Philips and Medical University of South Carolina Health Announce an 8-year, USD 36 Million Strategic Partnership to Transform Patient Monitoring

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) and Medical University of South Carolina Health (MUSC Health), the clinical enterprise of Medical University of South Carolina (MUSC), announced an 8-year, USD 36 million strategic partnership to transform and improve patient monitoring for more than one million patients a year. The strategic partnership is based on an enterprise managed services model through which Philips will install, integrate, and manage patient monitoring systems (including consumables) and software, as well as providing maintenance, training, and consulting services within a structured monthly payment model.

Serving patients across South Carolina and beyond through four hospital facilities in Charleston and more than 100 outreach sites, MUSC is now the fifth long-term, strategic partnership for Philips in North America. As hospital systems move from volume-based to value-based care, long-term, strategic partnerships are becoming the business model of choice for hospitals and health systems to better manage the cost and complexity of their technology investments, while expanding quality access to advanced medical care for their communities.

Philips is a leader in patient monitoring systems and software, with more than 275 million patients monitored by Philips systems annually. Through this long-term, strategic partnership, Philips will provide MUSC Health with continuous access to standardized, current-state patient monitoring technology, implementation, and asset management services. This approach helps MUSC to implement standardized clinical practice based on defined monitoring configurations and enable integration and interoperability with other clinical IT systems. Moreover, MUSC will have better collection and management of patient data in order to provide more informed, proactive diagnostic and treatment services, helping to reduce complications, adverse events, length of stay, and readmissions.

"We want to give our staff, learners, and patients access to the best patient monitoring technologies in order to deliver on the highest quality, safest, and most reliable healthcare through the use of Phillips patient monitoring equipment across our entire enterprise," said Patrick J. Cawley, MD, CEO, MUSC Health. "As one of the leading academic health centers in the country, whose value proposition is transforming expertise, learning and discovery into unrivaled patient-centered care in every setting, partnering with Philips will help us to meet our goal of delivering an exceptional patient care experience."

Long-term, strategic partnership models are well established globally and have demonstrated significant productivity improvements for pioneering Philips partners including Royal Belfast and Ashford St. Peters, and the New Karolinska Solna (NKS) hospital in Sweden. In less than a year, Philips has signed four long-term, strategic partnerships in North America including Westchester Medical Center Health Network (15 year term); Mackenzie Health (18 year term); and Marin General Hospital (15 year term).

"Due to a growing aging population and the rising number of people with chronic diseases, healthcare providers are seeking more cost-effective ways to monitor, diagnose, and treat patients," said Frans van Houten, CEO of Royal Philips. "As the healthcare industry is evolving, long-term, strategic partnerships are becoming the business model of choice, allowing health systems to address value-based models and keep pace with technology, while improving the patient experience. Together, Philips and MUSC can offer patients access to more than a century of experience in healthcare innovation and deliver an exceptional patient experience and quality care, while managing the rising healthcare costs."

MUSC is one of the nation's top academic health science centers, with a 750-bed medical center (MUSC Health) and six colleges. As South Carolina's only comprehensive academic health center providing a full range of programs in the biomedical sciences, MUSC is engaged in activities statewide. Its campus is located on more than 80 acres in the city of Charleston, with an overall population of about 13,000 clinicians, faculty, and staff, including nearly 3,000 students in six colleges (Dental Medicine, Graduate Studies, Health Professions, Medicine, Nursing, and Pharmacy) studying for degrees at the baccalaureate, masters, doctoral, and other professional levels.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ wholly owned subsidiary Philips Lighting is the global leader in lighting products, systems and services. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries.

About MUSC Health
MUSC Health is the clinical enterprise of the Medical University of South Carolina (MUSC) comprised of a 750-bed Medical Center, the MUSC College of Medicine and the physician’s practice plan. It serves patients across South Carolina and beyond through four hospital facilities in Charleston and more than 100 outreach sites. Among these are the Hollings Cancer Center, a National Cancer Institute-designated center, and a nationally recognized Children’s Hospital. The Medical University was founded in 1824 and has risen to become a premiere academic medical center at the forefront of the latest advances in medicine, with world-class physicians and other scientists and groundbreaking research and technology that is often the first of its kind in the world.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...